Disease/Infection News

RSS

Intermediate levels of indoor relative humidity shown to improve COVID-19 outcomes globally

In a new study, researchers found that indoor relative humidity modulates the severity of COVID-19 outbreaks, and intermediate RHs between 40 to 60% are robustly associated with better COVID-19 outcomes.

18 Nov 2022

Exploring the effect of herd immunity on monkeypox outbreak sizes

Researchers illustrated the baseline trajectory of the monkeypox virus (MPXV) epidemic anticipated under the sole effect of infection-derived or herd immunity.

18 Nov 2022

World Antimicrobial Awareness Week: Preventing Antimicrobial Resistance Together

In this interview, News-Medical talks to Dr Javier Yugueros-Marcos, Head of the Antimicrobial Resistance and Veterinary Products Department at the World Organisation for Animal Health, about how the world can work together to promote the sustainable and responsible use of antimicrobials.

18 Nov 2022

The antimicrobial activity of tee tree oil nanoliposomes against Escherichia coli

The main aim of the current study is to develop a new drug to promote sustainable and healthy animal husbandry in China.

18 Nov 2022

Pt(IV)-conjugated drug-delivery system shows efficacy in glioblastoma therapy

A recent study demonstrated a novel method for delivering anti-cancer drugs, conjugated to modified cell-penetrating peptides across the blood-brain barrier, in mice to treat glioblastoma.

18 Nov 2022

Clinical implementation of continuous genomic surveillance to identify, track, and interrupt the transmission of multidrug-resistant pathogenic bacteria

Scientists have developed a clinical WGS workflow that can detect transmission events of a pathogen before they become dominant.

18 Nov 2022

How gut microbes influence immune response to SARS-CoV-2

An article published in Critical Reviews in Food Science and Nutrition journal provides an overview of the role of gut microbiota in shaping the host immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Nov 2022

Study identifies risk factors and symptom clusters associated with long-COVID

A recent study posted to medRxiv* preprint server evaluated risk factors associated with long COVID.

17 Nov 2022

COVID-19 carries a much higher risk of epilepsy and seizures than influenza

COVID-19 increases risk of both seizures and epilepsy as compared to influenza infection

17 Nov 2022

Bispecific antibodies neutralize Sarbecoviruses with increased breadth and potency

In a recent study posted to the bioRxiv* preprint server, researchers developed bispecific antibodies (bsAbs), neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants.

17 Nov 2022

Gut microbiome plays a role in Alzheimer's

In a recent review published in the journal Pharmacological Research, researchers in Brazil investigated the role of gut microbiota in cognition, brain function, behavior, and neurodegenerative disease pathogenesis.

17 Nov 2022

WHO releases new data on worldwide influenza activity

The latest WHO report updated up to 30 October 2022 has data categorized by influenza transmission zones, i.e., countries/regions with similar influenza transmission patterns.

17 Nov 2022

What is the immune protection generated by SARS-CoV-2 Delta and Omicron BA.1 and BA.2 against Omicron BA.4 and BA.5?

Researchers evaluated immune protection conferred by previous SARS-CoV-2 Delta variant and Omicron BA.1/BA.2 subvariant infections and updated vaccines against Omicron BA.4/5 infections and associated hospitalizations.

17 Nov 2022

Evaluating differences in viral and symptom rebounds between Paxlovid-treated and untreated COVID-19 patients

Researchers evaluated differences in viral and symptom rebounds between Paxlovid-treated and untreated coronavirus disease 2019 (COVID-19) patients.

17 Nov 2022

What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?

Researchers examined the prevalence of contraindications to nirmatrelvir-ritonavir (Paxlovid) in hospitalized coronavirus disease 2019 (COVID-19) patients.

17 Nov 2022

Study describes distinct pattern of ongoing respiratory syncytial virus transmission in the Netherlands after the COVID-19 pandemic

Researchers assessed respiratory syncytial virus (RSV) transmission after the coronavirus disease 2019 (COVID-19) pandemic in the Netherlands.

17 Nov 2022

Comparing post–COVID-19 symptoms two years after SARS-CoV-2 infection

Researchers compared the presence of post–coronavirus disease 2019 (COVID-19) symptoms among hospitalized and non-hospitalized patients in Spain.

17 Nov 2022

Study reveals novel therapeutic targets for airway relaxation

Bronchial constriction is what makes many lung diseases like asthma so dangerous. Researchers have discovered a new signaling pathway that causes the airways to widen.

17 Nov 2022

Novel, student-driven, contact-tracing program reduced COVID-19 exposures

Epidemiologists at the University of Illinois Chicago (UIC) developed and implemented a novel, student-driven, contact-tracing program that reduced COVID-19 exposures and infections on the campus during the 2020-2021 school year. Results from the program, which deployed UIC students to conduct both COVID-19 case investigations and contact tracing among non-clinical campus members, were published today in the American Journal of Infection Control (AJIC).

17 Nov 2022

Protection afforded by SARS-CoV-2 infection against reinfection when Omicron BA.5 was the dominating subvariant in Scania county, Sweden

Researchers from Sweden conducted a cohort study to evaluate the protection granted by previous SARS-CoV-2 Omicron subvariant infections against reinfections among individuals vaccinated between June and August 2022.

17 Nov 2022

Disease/Infection News

Intermediate levels of indoor relative humidity shown to improve COVID-19 outcomes globally

Exploring the effect of herd immunity on monkeypox outbreak sizes

World Antimicrobial Awareness Week: Preventing Antimicrobial Resistance Together

The antimicrobial activity of tee tree oil nanoliposomes against Escherichia coli

Pt(IV)-conjugated drug-delivery system shows efficacy in glioblastoma therapy

Clinical implementation of continuous genomic surveillance to identify, track, and interrupt the transmission of multidrug-resistant pathogenic bacteria

How gut microbes influence immune response to SARS-CoV-2

Study identifies risk factors and symptom clusters associated with long-COVID

COVID-19 carries a much higher risk of epilepsy and seizures than influenza

Bispecific antibodies neutralize Sarbecoviruses with increased breadth and potency

Gut microbiome plays a role in Alzheimer's

WHO releases new data on worldwide influenza activity

What is the immune protection generated by SARS-CoV-2 Delta and Omicron BA.1 and BA.2 against Omicron BA.4 and BA.5?

Evaluating differences in viral and symptom rebounds between Paxlovid-treated and untreated COVID-19 patients

What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?

Study describes distinct pattern of ongoing respiratory syncytial virus transmission in the Netherlands after the COVID-19 pandemic

Comparing post–COVID-19 symptoms two years after SARS-CoV-2 infection

Study reveals novel therapeutic targets for airway relaxation

Novel, student-driven, contact-tracing program reduced COVID-19 exposures

Protection afforded by SARS-CoV-2 infection against reinfection when Omicron BA.5 was the dominating subvariant in Scania county, Sweden

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News